Christine Lagorce

Inserm — France

Medicine · Health Sciences

17h-index6.6kcitations66works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(33), Colorectal Cancer Surgical Treatments(24), Colorectal Cancer Treatments and Studies(20), Colorectal and Anal Carcinomas(18), Genetic factors in colorectal cancer(14)

Publications65 total

Multi-Institutional Evaluation of Pathologists’ Assessment Compared to Immunoscore
Cancers·2023· 10 citedOpen Access
Data from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Supplementary Figure 2 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Data from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
2023Open Access
Supplementary Figure 1 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Supplementary Tables 1 - 5 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Supplementary Figure 2 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Supplementary Tables 1 - 5 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Supplementary Figures from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
2023Open Access
Supplementary Tables from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
2023Open Access
Supplementary Figure 1 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Data from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Data from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
2023Open Access
Supplementary Figures from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
2023Open Access
Supplementary Tables from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
2023Open Access
Supplementary Figure 1 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Supplementary Figure 2 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Supplementary Tables 1 - 5 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Supplementary Figure 2 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Supplementary Tables 1 - 5 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Franck Pagès(26), Jérôme Galon(26), Florence Marliot(22), Amos Kirilovsky(22), Bernhard Mlecnik(21), Anne Berger(20), Gabriela Bindea(17), Nacilla Haicheur(17), Guy Zeitoun(17), Viorel Scripcariu(16), Maria-Gabriela Aniței(13), Carine El Sissy(12), Franck Zinzindohoué(11), Marc Van den Eynde(10), Patrick Bruneval(10), Robert Benamouzig(10), Ana-Maria Todosi(10), Tessa Fredriksen(9), Dan Ferariu(9), Mihai Danciu(9)